Vitrakvi Capsule
Product Images NDC 71777-390

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Vitrakvi (NDC 71777-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Loxo Oncology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 100 mg Carton Principal Panel (60 capsules)

VITRAKVI 100 mg capsules containing larotrectinib for oral use. The label specifies each capsule contains 100 mg larotrectinib (equivalent to 123 mg larotrectinib sulfate). The package contains 60 capsules and is labeled by Loxo Oncology, Inc. The design includes purple and blue wave patterns at the bottom.*

FDA Label Image

Image Of 25 mg Carton Principal Panel (60 capsules)

VITRAKVI 25 mg capsules containing larotrectinib, an oral human prescription drug by Loxo Oncology, Inc. The label states each capsule contains 25 mg larotrectinib (equivalent to 30.7 mg larotrectinib sulfate). The package includes 60 capsules for oral use.*

FDA Label Image

Image Of 20 mg/ml Carton Principal Panel (100 mL oral solution)

VITRAKVI oral solution 20 mg/mL label showing the product name, generic name larotrectinib, concentration 20 mg/mL, and quantity of 100 mL per bottle. The label indicates it is an oral solution for oral use by Loxo Oncology, Inc.*

FDA Label Image

Image Of The Chemical Structure Of Vitrakvi (Chem Struct)

Chemical structure of larotrectinib, the active ingredient in VITRAKVI. The image shows the molecular diagram including fluorophenyl, piperidine, and triazolopyrimidine groups, with a sulfate (H2SO4) moiety indicated.*

FDA Label Image

Image Of Supplies Needed To Take Or Give A Dose Of Vitrakvi Oral Solution (Fig A)

Illustration showing a bottle, a bottle adaptor, a 5 mL oral syringe, and a 1 mL oral syringe. The syringes are individually packaged and labeled with their volume. The bottle and adaptor are shown separately, likely for use with the syringes.*

FDA Label Image

Image Of How To Open The Bottle (Fig B)

Illustration labeled Figure B depicting hands opening a bottle by pressing down and turning the cap, showing the bottle grip and hand motion arrows.*

FDA Label Image

Image Of How To Insert The Adaptor Into The Bottle (Fig C)

An instructional diagram labeled Figure C showing the process of placing a cap onto a bottle. The image includes two bottles, one open and one capped, with an arrow indicating the cap being applied onto the open bottle.*

FDA Label Image

Image Of The Oral Syringe And A Close Up Of The Markings In mL (Fig D)

An instructional illustration labeled 'Figure D' showing a syringe with parts identified as tip, barrel, flange, and plunger. The close-up zoom highlights the syringe barrel with measurement markings from 1 to 3.*

FDA Label Image

Image Of Of How To Insert The Oral Syringe Into The Bottle (Fig E)

Illustration showing a hand holding a syringe above a vial held by another hand, with a downward arrow indicating insertion or injection of the syringe into the vial. The figure is labeled as 'Figure E'.*

FDA Label Image

Image Of How To Draw Vitrakvi Into The Oral Syringe For Proper Dose (Fig F)

An instructional illustration showing hands measuring liquid medication with a syringe. A close-up detail labels the syringe parts: tip, barrel, and the measurement to the top of the plunger, indicating volume markings at 1 mL and 2 mL.*

FDA Label Image

Image Of How To Expell Air Bubbles In The Oral Syringe (Fig G)

An instructional illustration showing how to draw liquid medication from a bottle using a syringe. The image depicts a hand holding a bottle inverted above a syringe, with arrows indicating the removal of air bubbles from the syringe.*

FDA Label Image

Image Of How To Remove The Oral Syringe From The Bottle (Fig H)

An instructional illustration showing a hand holding a syringe positioned above an open vial, with an upward arrow indicating the syringe is being pulled away from the vial. The image appears to demonstrate how to withdraw liquid medication from the vial.*

FDA Label Image

Image Of How To Properly Press The Plunger To Deliver The Dose (Fig I)

An instructional illustration showing a hand administering oral medication to a child using an oral syringe. The syringe is positioned near the child's mouth, indicating the proper method of oral dosing for liquid medication.*

FDA Label Image

Image Of Recapping The Bottle (Fig J)

Illustration demonstrating the action of twisting the cap off a vial or bottle, showing two hands with one holding the bottle and the other twisting the cap counterclockwise. The figure is labeled as Figure J.*

FDA Label Image

Image Of Removing The Plunger From The Barrel Of The Oral Syringe (Fig K)

Illustration figure K depicting two hands holding separate parts of a device or component, with arrows pointing in opposite directions indicating a pulling apart or separating action.*

FDA Label Image

Image Of Rinsing The Oral Syringe (plunger And Barrel) (Fig L)

An instructional illustration showing a hand holding a syringe under running water from a faucet, rinsing the syringe and allowing water to drip from it. Another syringe is depicted dripping water alongside.*

FDA Label Image

Image Of Re-insertion Of Plunger Into Oral Syringe Barrel (Fig M)

Illustration labeled Figure M showing two parts of a syringe: 1) the plunger and 2) the syringe barrel. The image depicts the components likely for instructional use related to drug administration or preparation.*

FDA Label Image

Image Of Cleaning Oral Syringe Using Warm Water (Fig N)

An instructional illustration showing two steps of using a syringe. The first step depicts pulling up the syringe plunger, and the second step shows pressing the plunger to release liquid from the syringe into a small container or dish below.*

FDA Label Image

Image Of Rinsing The Plunger And Barrel Of The Oral Syringe A 2nd Time (Fig O)

An instructional illustration labeled 'Figure O' showing a hand holding a small syringe or dosing device under running water, rinsing it while drops fall from another similar device. The image appears to demonstrate cleaning or rinsing of the dosing syringe for oral administration.*

FDA Label Image

Image Of Shaking Excess Water From The Barrel And Plunger (Fig P)

An instructional line drawing showing a hand holding a plunger-like device with arrows indicating a twisting or pulling motion. Drops fall from the device, suggesting fluid expulsion or dose delivery. The figure is labeled 'Figure P.'*

FDA Label Image

Image Of Where To Write The Date Of When The Bottle Was Opened (Fig Q)

An instructional line drawing showing a person holding a medicine bottle and using a pencil to write a date on a label affixed to the bottle's side. The label includes a printed date, demonstrating how to mark the date of first use or opening on medication packaging.*

FDA Label Image

Image Of 100 mg Label Principal Panel (60 capsules)

The label for VITRAKVI (larotrectinib) capsules shows the 100 mg strength. This oral human prescription drug label includes dosage instructions, storage conditions (20°C to 25°C), and a warning to keep out of reach of children. It is manufactured by Loxo Oncology, Inc. The label also features manufacturer logos for Bayer and Loxo Oncology and a barcode.*

FDA Label Image

Image Of 25 mg Label Principal Panel (60 capsules)

VITRAKVI 25 mg (larotrectinib) capsules label showing oral capsules in a 60-count package. The label includes dosage strength, storage instructions, prescription-only status, and the labeler Loxo Oncology, Inc. It also features logos for Bayer and Loxo, a barcode, and a QR code.*

FDA Label Image

Image Of 20 mg/ml Label Principal Panel (100 mL oral solution)

VITRAKVI (larotrectinib) oral solution 20 mg/mL label by Loxo Oncology, Inc. The label includes dosage instructions, storage information, a barcode, and company logos. It specifies the usual dose, storage at 2°C to 8°C, and a caution to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.